Glessner Coleen 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Glessner Coleen（CIK 1919170）在 1 家公司共报告 8 笔 SEC Form 4 内部人交易（最近一笔 2026-06-10）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-10 | Emergent BioSolutions Inc. (EBS) | EVP, Quality & Ethics, and CPL | 卖出 | 2,018 | $16,144 |
| 2026-05-01 | Emergent BioSolutions Inc. (EBS) | EVP, Quality & Ethics, and CPL | 买入 | 100,111 | $0 |
| 2026-03-05 | Emergent BioSolutions Inc. (EBS) | EVP, Quality & Ethics, and CPL | 卖出 | 8,199 | $69,200 |
| 2026-03-03 | Emergent BioSolutions Inc. (EBS) | EVP, Quality & Ethics, and CPL | 卖出 | 313 | $2,551 |
| 2026-02-10 | Emergent BioSolutions Inc. (EBS) | EVP, Quality & Ethics, and CPL | 卖出 | 28,847 | $315,009 |
| 2026-02-10 | Emergent BioSolutions Inc. (EBS) | EVP, Quality & Ethics, and CPL | 卖出 | 2,852 | $31,144 |
| 2025-10-16 | Emergent BioSolutions Inc. (EBS) | EVP, Quality & Ethics, and CPL | 卖出 | 30,608 | $306,080 |
| 2025-06-10 | Emergent BioSolutions Inc. (EBS) | EVP, Quality & Ethics, and CPL | 卖出 | 1,249 | $8,281 |
来源：SEC Form 4 申报文件 · 截至 2026-06-10